Compare Phapros Tbk. (PEHA) vs Sinergi Multi Lestarindo Tbk. (SMLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Phapros Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Phapros Tbk. trades at Rp300 (market cap 221.76B, 7.89M 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp168 (market cap 412.08B, 19.74M 24h volume). The key difference: Sinergi Multi Lestarindo Tbk. is the larger of the two by market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (19.74M versus 7.89M). Which is the better fit depends on your goals.
| PEHA | SMLE | |
|---|---|---|
Market Cap | 221.76B | 412.08B |
Volume | 7.89M | 19.74M |
Lot | 78.91K | 197.37K |
Turnover | 2.48B | 3.38B |
Average Price | 314.91 | 171.01 |
Value | 2.48B | 3.38B |
Indicative Equilibrium Price | 300 | 168 |
Indicative Equilibrium Volume | 1.06K | 1.2K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Phapros Tbk.
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →About Sinergi Multi Lestarindo Tbk.
PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →
